C-MER Medical Holdings Limited (3309.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological services and the retail of vision-enhancing products. Established by Shun Chiu Lam on February 1, 2016, the organization's corporate headquarters are situated in Hong Kong.

Industry: Medical - Care Facilities
Sector: Healthcare
Headquarters: HK
CEO: Xiaoting Li
Listed since: Jan 15, 2018
Employees: 2,200

Market position

Day range

Current HK$0.855

HK$0.85HK$0.86

52-week range

Current HK$0.855

HK$0.84HK$2.16

Open: HK$0.86
Previous close: HK$0.85
Volume: 116K; 0.33× average
Average volume: 356.05K; Average daily volume
Market cap: 1.02B HKD
Beta: 0.54; Market reference 1
50-day average: HK$0.9448; -9.50% below average
200-day average: HK$1.3229; -35.37% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 2.15B HKD
P/E (TTM): 10.28×
P/B (TTM): 0.58×
P/S (TTM): 0.52×
EV / EBITDA: 10.42×
Earnings yield: 4.84%
Free cash flow yield: 10.80%
Dividend yield: 3.51%

Profitability & efficiency

Gross margin: 31.01%
Operating margin: 8.60%
Net margin: 5.16%
Return on equity: 5.65%
Return on assets: 3.67%
Return on invested capital: 4.92%

Financial health

Debt / equity: 0.24×
Current ratio: 1.43×
Altman Z-score: 2.62
Piotroski F-score: 5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.95B HKD+1.75%

Operating income

167.47M HKD+233.63M HKD

Net income

100.37M HKD+235.53M HKD

Metric (HKD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.95B HKD	1.91B HKD	1.92B HKD	1.73B HKD	1.11B HKD
Cost of goods sold	1.34B HKD	1.39B HKD	1.31B HKD	1.37B HKD	803.14M HKD
Gross profit	603.67M HKD	527.62M HKD	618.96M HKD	365.34M HKD	309.44M HKD
Selling, general, and administrative	472.05M HKD	475.98M HKD	502.73M HKD	472.12M HKD	360.56M HKD
Operating expenses	436.2M HKD	593.78M HKD	499.63M HKD	484.18M HKD	333.49M HKD
Interest income	12.97M HKD	14.57M HKD	19.89M HKD	7.11M HKD	4.48M HKD
Interest expense	24.34M HKD	23.66M HKD	18.12M HKD	19.66M HKD	13M HKD
Depreciation and amortization	63.91M HKD	79.51M HKD	220.99M HKD	223.68M HKD	148.58M HKD
Operating income	167.47M HKD	−66.16M HKD	119.34M HKD	−36.48M HKD	24.74M HKD
Net income	100.37M HKD	−135.16M HKD	62M HKD	−21.88M HKD	21.86M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result: 0.04

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Estimates unavailable

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.02

2025 complete year0.0% since 2019

2026 partial: HK$0.03

HK$0.02

2,019

HK$0.02

2,020

HK$0.02

2,021

HK$0.02

2,025

HK$0.03

2,026*

* Partial calendar year in the available dividend history.

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
Dividend	Jun 29, 2026	HK$0.03Special	Jul 2, 2026	Jul 15, 2026
Dividend	Jun 27, 2025	HK$0.02Irregular	Jul 2, 2025	Jul 15, 2025
Dividend	May 31, 2021	HK$0.02Annual	Jun 1, 2021	Jun 28, 2021
Dividend	May 22, 2020	HK$0.02Annual	May 25, 2020	Jun 22, 2020
Dividend	Jun 27, 2019	HK$0.02Annual	Jun 28, 2019	Jul 15, 2019